Salk Institute researchers, in collaboration with the National Institutes of Health, have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most effective, clinically used antiviral drugs for treating HIV.
Diverting Acute HF Patients From Hospitalization: Case Builds for Short Stay Units
For patients presenting to the emergency department (ED) with acute heart failure (AHF), sending select low-risk individuals to the short stay unit (SSU) did not
January 12, 2024